Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib

A. S. Mansfield, S. J. Murphy, F. R. Harris, S. I. Robinson, R. S. Marks, S. H. Johnson, J. B. Smadbeck, G. C. Halling, E. S. Yi, D. Wigle, G. Vasmatzis, J. Jen

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'Chromoplectic TPM3-ALK rearrangement in a patient with inflammatory myofibroblastic tumor who responded to ceritinib after progression on crizotinib'. Together they form a unique fingerprint.

Medicine & Life Sciences